Tool · Investor plan
Screener
Find the companies matching your criteria among 537 large listed companies in the United States and Europe, updated daily.
44 companies match
| # | Company | Score ↑ | Op. margin | Growth | ROE | Debt / equity | FCF margin | Revenue | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Revolution Medicines, Inc.RVMD | 9 | – | – | −58.1% | – | – | $0 | |
| 2 | Moderna, Inc.MRNA | 30 | −158.1% | −39.9% | −28.9% | 0.07× | −106.2% | $1.9B | |
| 3 | Natera, Inc.NTRA | 39 | −13.4% | +35.9% | −14.3% | 0.05× | 4.7% | $2.3B | |
| 4 | Takeda Pharmaceutical Company Limited4502 | 46 | 0.1% | −1.7% | −2.1% | 0.66× | 19.2% | ¥4.5T | |
| 5 | TAKEDA PHARMACEUTICAL CO LTDTAK | 50 | 7.5% | +7.5% | 1.5% | 0.65× | 18.7% | ¥4.6T | |
39 more results with the Investor plan: full screener, rankings and export. Try free for 7 days → | |||||||||
Data updated October 24, 2026. European companies: selection of the largest listings.